Envista (NVST) Stock Price, News & Analysis

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Envista in the last year. There are currently 3 sell ratings, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NVST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVST, but not buy additional shares or sell existing shares.
View NVST analyst ratings or view top-rated stocks.

11 brokerages have issued 12-month target prices for Envista's stock. Their NVST share price targets range from $19.00 to $45.00. On average, they predict the company's share price to reach $29.60 in the next twelve months. This suggests a possible upside of 54.5% from the stock's current price.
View analysts price targets for NVST or view top-rated stocks among Wall Street analysts.

Envista's stock was trading at $24.06 on January 1st, 2024. Since then, NVST shares have decreased by 20.4% and is now trading at $19.16.
View the best growth stocks for 2024 here.

Envista saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 10,840,000 shares, an increase of 23.9% from the March 15th total of 8,750,000 shares. Based on an average daily volume of 2,450,000 shares, the days-to-cover ratio is currently 4.4 days.
View Envista's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NVST earnings forecast.

Envista will be holding an earnings conference call on Wednesday, May 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Envista Holdings Co. (NYSE:NVST) released its earnings results on Wednesday, February, 7th. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by $0.04. The firm had revenue of $645.60 million for the quarter, compared to the consensus estimate of $638.37 million. Envista had a negative net margin of 3.90% and a positive trailing twelve-month return on equity of 6.31%. The firm's quarterly revenue was down 2.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.52 EPS.

ETFs with the largest weight of Envista (NYSE:NVST) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), SPDR S&P Health Care Equipment ETF (XHE), Royce Quant Small-Cap Quality Value ETF (SQLV), Vanguard S&P Mid-Cap 400 Value ETF (IVOV), iShares U.S. Medical Devices ETF (IHI) and iShares S&P Mid-Cap 400 Value ETF (IJJ).Dimensional US Small Cap Value ETF (DFSV).

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Envista (NVST) raised $603 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,800,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Envista's stock is owned by many different institutional and retail investors. Top institutional investors include NBC Securities Inc. (0.01%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Eric Conley, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance, Mischa Reis and Stephen Keller.
View institutional ownership trends.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.